For the Quarter Ending December 2025
Escitalopram Oxalate Prices in North America
- In the United States, the Escitalopram Oxalate Price Index rose in Q4 2025, driven by increasing production costs and stable demand.
- Escitalopram Oxalate production costs increased in Q4 2025, influenced by a 3.0% PPI rise in November 2025.
- Demand for Escitalopram Oxalate remained stable in Q4 2025, supported by a 4.4% unemployment rate in December 2025.
- Henry Hub natural gas prices strengthened in November and December 2025, increasing energy inputs for chemical production.
- General inflation, with CPI rising 2.7% year-over-year in December 2025, contributed to higher raw material expenses.
- Overall industrial production increased by 2.0% year-over-year in December 2025, supporting pharmaceutical manufacturing stability.
- US imports and exports of pharmaceutical preparations decreased in October 2025, impacting overall trade dynamics.
- Total Industrial Production inched up in Q4 2025, with Capacity Utilization also rising in December 2025.
Why did the price of Escitalopram Oxalate change in December 2025 in North America?
- Rising production costs in Q4 2025, driven by a 3.0% PPI increase in November 2025, impacted Escitalopram Oxalate pricing.
- Strengthening Henry Hub natural gas prices in November and December 2025 elevated energy expenses for chemical manufacturing.
- A 2.7% CPI rise in December 2025 reflected broader inflationary pressures on raw materials and operational overheads.
Escitalopram Oxalate Prices in APAC
- In China, the Escitalopram Oxalate Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer costs.
- Escitalopram Oxalate production costs decreased in Q4 2025, with producer prices falling 1.9% year-over-year in December 2025.
- Demand for Escitalopram Oxalate remained stable in Q4 2025, supported by healthy global Active Pharmaceutical Ingredient market growth.
- China's manufacturing index expanded in December 2025, indicating a healthy industrial environment for Escitalopram Oxalate supply.
- Industrial production grew 5.2% year-over-year in December 2025, supporting robust Escitalopram Oxalate production volumes.
- Overall chemical input costs faced downward pressure in 2025 due to oversupply, impacting Escitalopram Oxalate production expenses.
- Chinese electricity prices experienced downward pressure in Q4 2025, contributing to lower energy costs for manufacturing.
- Asian spot LNG prices climbed in November 2025, exerting upward pressure on some energy-related production costs.
- China's chemical exports increased between October and November 2025, reflecting strong external demand for chemical products.
- The prices for Escitalopram Oxalate in Q4, 2025 settled at USD 2160/MT in Asia.
Why did the price of Escitalopram Oxalate change in December 2025 in APAC?
- Producer prices declined 1.9% year-over-year in December 2025, reducing Escitalopram Oxalate manufacturing costs.
- Overall chemical input costs faced downward pressure in 2025 due to oversupply, lowering production expenses.
- Low consumer inflation at 0.8% year-over-year in December 2025 indicated broader economic weakness.
Escitalopram Oxalate Prices in Europe
- In Germany, the Escitalopram Oxalate Price Index fell quarter-over-quarter in Q4 2025, influenced by declining industrial producer prices.
- Escitalopram Oxalate production costs faced downward pressure from a -2.5% Producer Price Index in December 2025.
- Demand for Escitalopram Oxalate was supported by increased pharmaceutical output in Germany during 2025.
- The Manufacturing Index contracted in December 2025, indicating a slowdown in overall economic activity.
- Consumer confidence remained significantly negative at -17.5 in December 2025, impacting healthcare spending.
- Elevated European natural gas prices in 2025 contributed to uncompetitive production costs for the German chemical industry.
- Industrial production grew by 0.8% in October 2025, while retail sales increased by 1.1% in November 2025.
- A stable Consumer Price Index at 1.8% in December 2025 supported overall economic stability despite moderate unemployment.
Why did the price of Escitalopram Oxalate change in December 2025 in Europe?
- Declining industrial producer prices, down 2.5% in December 2025, reduced Escitalopram Oxalate manufacturing input costs.
- A contracting Manufacturing Index in December 2025 and negative consumer confidence dampened overall demand.
- Elevated European natural gas prices in 2025 contributed to uncompetitive production costs for the German chemical sector.
For the Quarter Ending September 2025
Escitalopram Oxalate Prices in APAC
- In China, the Escitalopram Oxalate Price Index fell in Q3 2025, influenced by a -2.3% year-on-year decline in producer prices.
- Production costs showed mixed trends, with naphtha feedstock firming and natural gas prices rising in Q3 2025.
- Demand for Escitalopram Oxalate was supported by rising chronic disease treatments and bolstered psychiatric care.
- The Manufacturing Index was Contracting in September 2025, while industrial production expanded by 6.5% year-on-year.
- Retail sales increased by 3.0% year-on-year in September 2025, despite a -0.3% year-on-year CPI decrease.
- The unemployment rate was 5.2% in September 2025, suggesting some economic pressure on consumers.
- Domestic inventories remained comfortable in Q3 2025, with US tariffs expected to elevate API costs.
- Escitalopram Oxalate price forecast remains under pressure, reflecting bearish consumer confidence (89.6 in September 2025).
Why did the price of Escitalopram Oxalate change in September 2025 in APAC?
- Producer prices declined -2.3% year-on-year in September 2025, contributing to lower input costs.
- Naphtha feedstock costs firmed and natural gas prices rose in Q3 2025, increasing production expenses.
- Strong demand for chronic disease treatments was partially countered by contracting manufacturing activity.
Escitalopram Oxalate Prices in Europe
- In Germany, the Escitalopram Oxalate Price Index fell in Q3 2025, influenced by declining industrial production.
- Escitalopram Oxalate production costs faced mixed pressures, with producer prices falling 1.7% in September 2025.
- Demand was constrained by Germany's stagnating economic activity and industrial production declining 1.0% in September 2025.
- The Escitalopram Oxalate Price Index is forecast to remain stable due to market overcapacity in Q3 2025.
- Germany's Manufacturing Index was contracting in Q3 2025, reflecting a broader economic slowdown.
- European natural gas prices declined year-on-year in Q3 2025, easing some Escitalopram Oxalate production costs.
- Overcapacity in the European chemical industry and declining German exports impacted Escitalopram Oxalate trade.
- Consumer Price Index rose 2.4% in September 2025, increasing general manufacturing and distribution costs.
Why did the price of Escitalopram Oxalate change in September 2025 in Europe?
- Producer prices fell 1.7% in September 2025, reducing Escitalopram Oxalate manufacturing costs.
- Germany's Manufacturing Index contracted in Q3 2025, signaling weaker industrial demand.
- European chemical overcapacity and declining German exports pressured Escitalopram Oxalate prices.
Escitalopram Oxalate Prices in North America
- In the United States, Escitalopram Oxalate Price Index rose in Q3 2025, driven by robust demand and rising costs.
- Price Forecast suggests continued upward pressure from sustained healthcare spending and increasing input expenses.
- Production costs increased, influenced by a 2.6% PPI rise in August 2025 and higher natural gas feedstock.
- Demand outlook remained strong, supported by 5.42% retail sales increase and 4.3% unemployment in September 2025.
- General inflation, with CPI up 3.0% year-over-year in September 2025, impacted operational costs.
- Biopharma industry momentum gathered in Q3 2025, with new US FDA drug approvals boosting demand.
- Trade flows faced disruption from tariff uncertainty in Q3 2025; US chemical exports and imports softened.
- Industrial production increased 0.1% year-on-year in September 2025, indicating stable manufacturing activity.
- Consumer confidence declined to 94.2 in September 2025, potentially affecting patient treatment seeking.
Why did the price of Escitalopram Oxalate change in September 2025 in North America?
- Rising production costs, with PPI up 2.6% in August 2025, directly impacted manufacturing expenses.
- Strong consumer spending, retail sales up 5.42% in September 2025, bolstered patient access and demand.
- General inflation, CPI rising 3.0% in September 2025, contributed to higher operational and raw material costs.
